Your browser doesn't support javascript.
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study.
Lozano-Rodríguez, Roberto; Terrón-Arcos, Verónica; Montalbán-Hernández, Karla; Casalvilla-Dueñas, José Carlos; Bergón-Gutierrez, Marta; Pascual-Iglesias, Alejandro; Quiroga, Jaime Valentín; Aguirre, Luis A; Pérez de Diego, Rebeca; Vela-Olmo, Carmen; López-Morejón, Lissette; Martín-Quirós, Alejandro; Del Balzo-Castillo, Álvaro; Peinado-Quesada, María A; García-Garrido, Miguel A; Gómez-Lage, Laura; Herrero-Benito, Carmen; Llorente-Fernández, Irene; Martín-Miguel, Gema; Torrejón, Margarita; Cubillos-Zapata, Carolina; Del Fresno, Carlos; Avendaño-Ortiz, José; López-Collazo, Eduardo.
  • Lozano-Rodríguez R; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Terrón-Arcos V; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Montalbán-Hernández K; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Casalvilla-Dueñas JC; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Bergón-Gutierrez M; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Pascual-Iglesias A; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Quiroga JV; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Aguirre LA; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Pérez de Diego R; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Vela-Olmo C; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • López-Morejón L; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Martín-Quirós A; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Del Balzo-Castillo Á; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Peinado-Quesada MA; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • García-Garrido MA; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Gómez-Lage L; Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Herrero-Benito C; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Llorente-Fernández I; Eurofins-Ingenasa, Madrid, Spain.
  • Martín-Miguel G; Eurofins-Ingenasa, Madrid, Spain.
  • Torrejón M; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Cubillos-Zapata C; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Del Fresno C; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Avendaño-Ortiz J; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • López-Collazo E; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
Clin Transl Med ; 12(5): e869, 2022 05.
Article in English | MEDLINE | ID: covidwho-1838172
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Transl Med Year: 2022 Document Type: Article Affiliation country: Ctm2.869

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Transl Med Year: 2022 Document Type: Article Affiliation country: Ctm2.869